Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.52 USD | +2.03% | +8.31% | -19.63% |
Apr. 17 | Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024 | CI |
Apr. 15 | Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.63% | 88.62M | |
+4.06% | 70.44B | |
+10.97% | 8.94B | |
-14.44% | 4.75B | |
+41.60% | 4.5B | |
+5.96% | 3.85B | |
+23.46% | 2.38B | |
-19.32% | 2.34B | |
-27.04% | 2.2B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- Eton Pharmaceuticals to Acquire Nitisinone Drug From Oakrum Pharma